| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0084 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |